Ticker brief
NNVC NANOVIRICIDES INC
Consumer, Non-cyclical · Pharmaceuticals
last close
$1.30
1 day
-5.8%
14 days
-10.3%
mkt cap
$30.6M
signals 14d
5
authors 14d
3
crowd 14d
+0.15
Sentiment — last 14 days
daily mean sentiment, 2026-10-04 → 2026-10-13 · now +0.35 (−1 bearish … +1 bullish)
Who spoke3
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @AccesswireNews | C | · | 2 | +0.05 |
| @OzmosiHealth | C | · | 2 | +0.22 |
| @DavidScottAdams | C | -2.62 | 1 | +0.15 |
Recent signals5of 5 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-13 | @OzmosiHealth | +0.35 | NanoViricides says its Phase 2 NV-387 Ebola trial is progressing well. | -1.5% | tweet ↗ |
| 2026-10-06 | @AccesswireNews | +0.00 | NanoViricides announces an October 7, 2026 conference presentation. | -7.1% | tweet ↗ |
| 2026-10-05 | @OzmosiHealth | +0.10 | NanoViricides provided additional details on its Phase 2 Ebola-treatment trial. | -10.3% | tweet ↗ |
| 2026-10-05 | @AccesswireNews | +0.10 | NanoViricides provides an operational update on its Phase II NV-387 clinical trial. | -10.3% | tweet ↗ |
| 2026-10-04 | @DavidScottAdams | +0.15 | Provides a swing-trading watchlist for tomorrow without entry intent. | +1.6% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.